Guest guest Posted January 2, 2003 Report Share Posted January 2, 2003 This is from the Houston Chronicle today: " WASHINGTON - The government has approved sale of a new drug for rheumatoid arthritis that works like two older competitors - but may prove easier to take. Abbott Laboratories' Humira works by blocking an immune system protein called tumor necrosis factor, or TNF, that is responsible for much of the pain and inflmmation of rheumatoid arthritis. It requires patients to give themselves one shot every two weeks. Two other TNF blockers, Enbrel and Remicade, have long been sold. Enbrel requires two shots a week, and is so difficult to manufacture that it's often in short supply. Remicade requires an infusion in a doctor's office. All three drugs have similar side effects, including serious, sometimes fatal, infections thought to be linked to the suppression of the immune protein. About 2 million Americans have rheumatoid arthritis, where the immune system goes awry and destroys patients' joints. " I wonder how it will work with PA? J Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.